#United States #Austin #Life Sciences #Texas Bioscience #THBI

Strategic Vision for Texas Life Sciences

On March 30, 2026, the Texas Healthcare and Bioscience Institute (THBI) unveiled a thorough report outlining a strategic vision to strengthen the life sciences and biotechnology landscape of Texas. Titled "Texas Life Sciences Driving Innovation, Patient Care & Economic Growth," the report highlights the rapid expansion and innovation within the state, presenting actionable recommendations to maintain Texas' leadership in the biosciences.

The Growth of Texas Biosciences

Texas has ascended to the forefront of the bioscience sector in the United States. According to the report, the Texas bioscience industry employed approximately 129,245 individuals across 9,212 establishments as of 2023, exhibiting a remarkable 21.6% employment increase since 2019. This growth is indicative of the robust infrastructure, increasing workforce, and supportive regulatory environment.

Key statistics featured in the report include:

• - $4.6 billion in academic research and development expenditures in biosciences for 2022, ranking Texas third nationally.
• - $1.8 billion in NIH funding allocated to local institutions in 2023, marking a 34% rise since 2019.
• - $8.7 billion raised from venture capital by Texas bioscience companies from 2019 to 2023, placing the state fifth in national rankings.
• - Nearly 8,000 patents related to biosciences granted to Texas innovators between 2019 and 2023, ranking ninth in the nation.

Recommendations for a Bright Future

To fortify Texas's role as a leader in life sciences, the report emphasizes the necessity for policy adaptations and enhanced collaboration among governmental entities, academic institutions, and industry stakeholders. The recommendations include:

• - Investing in modernizing research infrastructure to accelerate the pace of innovation.
• - Promoting the commercialization of scientific breakthroughs to improve accessibility to new technologies.
• - Encouraging partnerships that enhance workforce education and training within the biosciences field.

The overarching goal identified by THBI is to solidify Texas's global competitiveness by fostering a dynamic environment that encourages collaboration and innovation.

Upcoming Texas Life Sciences Summit

Coinciding with the release of this report, the annual Texas Life Sciences Summit is scheduled to take place from March 31 to April 1 in Austin. This event will gather leaders across healthcare, biotechnology, academia, and policy to discuss significant trends and innovations shaping the future of the life sciences in Texas.

The insights provided in the report are designed to catalyze productive conversations aimed at enhancing the state's biosciences ecosystem, facilitating collaboration, and stimulating economic growth across Texas.

For media inquiries regarding the Texas Life Sciences Summit, participants are encouraged to reach out to [email protected]

About THBI

The Texas Healthcare and Bioscience Institute serves as the principal public policy voice for the healthcare and bioscience sectors in Texas. The organization is committed to driving scientific advancements aimed at developing innovative medications and therapies ultimately benefiting patients. With 30 years of dedicated service, THBI is instrumental in fostering an environment conducive to scientific discoveries and breakthroughs.

For further details about THBI or to access the full report, please visit www.thbi.com.